Learn More
Medchemexpress LLC N-(2-(1H-indol-3-yl)ethyl)-5-(5-fluoropyridin-3-yl)-3-methylpyrazolo[1,5-a]pyrimidin-7-amine | 2247950-73-6 | 98.0% | C22H19FN6 | 10MG

Supplier: Medchemexpress LLC HY13421710MG
KYN-101 is a small-molecule, selective, orally active antagonist of the aryl hydrocarbon receptor (AHR) supplied for laboratory research. It reduces CYP1A1 mRNA expression and has demonstrated anti-cancer activity in preclinical studies, making it suitable for mechanistic studies of AHR signaling and oncology research.
- Selective AHR inhibition with reported nanomolar potency.
- Orally active in preclinical models.
- Reduces CYP1A1 mRNA expression in cellular assays.
- Useful for mechanistic studies of AHR signaling and cancer biology.
- Available as solid and ready-to-use DMSO solutions for assay setup.
- High purity suitable for research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.